Showing 1 to 5 of 5 results
Lawsuit Challenges AbbVie's Humira Pricing, Highlighting Drug Cost Debate
A Dutch foundation is suing AbbVie for excessive profits from Humira, arguing its high price displaced other healthcare needs; AbbVie counters that high prices are needed to cover development costs, and the patent expiry in 2018 caused prices to plummet by nearly 90% by 2023.
Lawsuit Challenges AbbVie's Humira Pricing, Highlighting Drug Cost Debate
A Dutch foundation is suing AbbVie for excessive profits from Humira, arguing its high price displaced other healthcare needs; AbbVie counters that high prices are needed to cover development costs, and the patent expiry in 2018 caused prices to plummet by nearly 90% by 2023.
Progress
60% Bias Score
Financial Strain Exacerbates Mental Health Crisis in NSW
A new report reveals that over half of NSW residents reported worsened mental health due to financial strain, coinciding with a 10% increase in loneliness; Joanne Cockle postponed a medical appointment due to unaffordable gap fees, highlighting the financial barriers to healthcare access.
Financial Strain Exacerbates Mental Health Crisis in NSW
A new report reveals that over half of NSW residents reported worsened mental health due to financial strain, coinciding with a 10% increase in loneliness; Joanne Cockle postponed a medical appointment due to unaffordable gap fees, highlighting the financial barriers to healthcare access.
Progress
36% Bias Score
Australian Adults Pay More for GP Visits Despite Government Bulk-Billing Investment
Analysis of Medicare data reveals that while the Albanese government's \$3.5 billion investment in bulk billing increased free GP visits for children and older Australians, adults aged 16 to 64 are paying more for GP appointments, with bulk-billing rates declining and out-of-pocket costs rising from...
Australian Adults Pay More for GP Visits Despite Government Bulk-Billing Investment
Analysis of Medicare data reveals that while the Albanese government's \$3.5 billion investment in bulk billing increased free GP visits for children and older Australians, adults aged 16 to 64 are paying more for GP appointments, with bulk-billing rates declining and out-of-pocket costs rising from...
Progress
56% Bias Score
US GLP-1 Drug Affordability Crisis
High costs and limited insurance coverage of GLP-1 weight-loss drugs like Ozempic and Wegovy are creating an affordability crisis in the US, with millions losing coverage in 2025; potential solutions include allowing compounding pharmacies to produce personalized prescriptions and revoking patent ex...
US GLP-1 Drug Affordability Crisis
High costs and limited insurance coverage of GLP-1 weight-loss drugs like Ozempic and Wegovy are creating an affordability crisis in the US, with millions losing coverage in 2025; potential solutions include allowing compounding pharmacies to produce personalized prescriptions and revoking patent ex...
Progress
52% Bias Score
NHS Weight-Loss Jab: High Cost Limits Access for Millions
Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.
NHS Weight-Loss Jab: High Cost Limits Access for Millions
Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.
Progress
52% Bias Score
Showing 1 to 5 of 5 results